Sloviter, R
However, these compounds were not specifically designed to utilize LAT1 for brain delivery
If you feel you are not achieving your desired outcomes with your current dose, please schedule a consultation with our team
Daniel Strbian: Scientific advisory board Boehringer-Ingelheim and Astra Zeneca E-Posters - RISK FACTORS - PRIMARY AND SECONDAR PREVENTION 05.00 - RISK FACTORS AND PREVENTION (PRIMARY AND SECONDARY) - 05.03 - EPIDEMIOLOGY & RISK FACTORS P2543 - ESOC25-1742 OLD ISCHEMIC LESIONS ON MRI IN THE EMERGENCY DEPARTMENT ASSOCIATED COMORBIDITIES OF ACUTE STROKE AND TIA VERSUS NON-STROKE CONDITIONS Malini Sagar 1,2 , Christian Krag 2,3,4 , Karen Lind Gandrup 3 , Mikael Boesen 2,4,5 , Christina Kruuse 1,2,6 1 Department of Neurology, Copenhagen University Hospital - Herlev and Gentofte, Copenhagen, Denmark, 2 Institute of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark, 3 Department of Radiology, Copenhagen University Hospital - Herlev and Gentofte, Copenhagen, Denmark, 4 Radiological AI Test Center (RAIT.dk), Copenhagen University Hospital - Herlev and Gentofte & Bispebjerg and Frederiksberg, Copenhagen, Denmark, 5 Department of Radiology, Copenhagen University Hospital - Bispebjerg and Frederiksberg, Copenhagen, Denmark, 6 Department of Brain and Spinal Cord Injury, Copenhagen University Hospital - Rigshospitalet Glostrup, Glostrup, Denmark Background and Aims: Old ischemic lesions on magnetic resonance imaging (MRI), among patients without ischemic stroke or transitory ischemic attack (TIA), cause occasional therapeutic dilemmas
Individuals with active cancer (discuss with oncologist due to its immune-stimulating properties) Those taking immunosuppressive drugs (e.g., post-transplant patients) Pregnant or breastfeeding individuals (not studied in this population) No Known Interactions Thymalin can be safely stacked with most peptide therapies, medications, and supplements
